JP Morgan Chase
RXST icon

JP Morgan Chase’s RxSight RXST Stock Holding History

JP Morgan Chase’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Sell
82,607
-406,034
-83% -$2.45M ﹤0.01% 5214
2026
Q1 		$2.98M Buy
488,641
+236,043
+93% +$1.96M ﹤0.01% 3785
2025
Q4 		$2.63M Buy
252,598
+149,716
+146% +$1.5M ﹤0.01% 3871
2025
Q3 		$925K Buy
102,882
+68,735
+201% +$603K ﹤0.01% 4649
2025
Q2 		$444K Sell
34,147
-128,656
-79% -$1.93M ﹤0.01% 4846
2025
Q1 		$4.11M Buy
162,803
+128,406
+373% +$3.82M ﹤0.01% 3329
2024
Q4 		$1.18M Sell
34,397
-158,113
-82% -$7.13M ﹤0.01% 4513
2024
Q3 		$9.52M Buy
192,510
+7,494
+4% +$384K ﹤0.01% 2646
2024
Q2 		$11.1M Sell
185,016
-125,944
-41% -$7.2M ﹤0.01% 2366
2024
Q1 		$16M Sell
310,960
-285,580
-48% -$14M ﹤0.01% 2073
2023
Q4 		$24.1M Buy
596,540
+44,975
+8% +$1.32M ﹤0.01% 1694
2023
Q3 		$15.4M Buy
551,565
+11,431
+2% +$341K ﹤0.01% 1884
2023
Q2 		$15.6M Sell
540,134
-25,372
-4% -$564K ﹤0.01% 1902
2023
Q1 		$9.43M Buy
565,506
+553,820
+4,739% +$7.82M ﹤0.01% 2334
2022
Q4 		$148K Buy
11,686
+434
+4% +$5.28K ﹤0.01% 5185
2022
Q3 		$135K Buy
11,252
+243
+2% +$3.34K ﹤0.01% 5146
2022
Q2 		$155K Buy
11,009
+2,782
+34% +$36.7K ﹤0.01% 5201
2022
Q1 		$102K Buy
8,227
+2,820
+52% +$33.9K ﹤0.01% 5501
2021
Q4 		$61K Buy
5,407
+1,362
+34% +$16.4K ﹤0.01% 5869
2021
Q3 		$51K Buy
+4,045
New +$55.7K ﹤0.01% 5837

Other funds holding RXST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

JP Morgan Chase's RXST Position: Q2 2026 in Review

JP Morgan Chase reduced its RxSight (RXST) stake by 83% in Q2 2026, selling an estimated $2.45M and leaving 82,607 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #5214.

JP Morgan Chase first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $24.1M in Q4 2023. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • JP Morgan Chase held 82,607 shares of RxSight worth $421K as of Q2 2026.
  • JP Morgan Chase sold 406,034 RxSight shares in Q2 2026, an estimated $2.45M.
  • RxSight made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5214 holding.
  • JP Morgan Chase first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's RxSight position peaked at $24.1M in Q4 2023.
  • 151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.